DADC
AVNS

D.A. Davidson & Co’s Avanos Medical AVNS Stock Holding History

D.A. Davidson & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,102
Closed -$43K – 1145
2017
Q2 		$43K Sell
1,102
-56
-5% -$2.12K ﹤0.01% 1575
2017
Q1 		$44K Sell
1,158
-5,368
-82% -$209K ﹤0.01% 1565
2016
Q4 		$240K Buy
6,526
+399
+7% +$14.3K 0.01% 918
2016
Q3 		$211K Buy
6,127
+171
+3% +$5.99K 0.01% 923
2016
Q2 		$193K Buy
5,956
+76
+1% +$2.33K 0.01% 856
2016
Q1 		$168K Buy
5,880
+464
+9% +$12.4K 0.01% 909
2015
Q4 		$179K Sell
5,416
-2,334
-30% -$72.6K 0.01% 877
2015
Q3 		$218K Sell
7,750
-1,329
-15% -$46.4K 0.01% 793
2015
Q2 		$366K Buy
9,079
+1,611
+22% +$72.3K 0.01% 665
2015
Q1 		$365K Sell
7,468
-1,395
-16% -$64.6K 0.01% 667
2014
Q4 		$401K Buy
+8,863
New +$348K 0.01% 647

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.A. Davidson & Co's AVNS Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 1,102 shares — an estimated $43K sold.

D.A. Davidson & Co first reported a position in AVNS in Q4 2014 and held it in 11 quarters. The position peaked at $401K in Q4 2014. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,102 Avanos Medical shares in Q3 2017, an estimated $43K.
  • D.A. Davidson & Co first reported a position in Avanos Medical in Q4 2014 and held it in 11 quarters.
  • D.A. Davidson & Co's Avanos Medical position peaked at $401K in Q4 2014.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.